Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Fluorescence Imaging of Peripheral Nerves by a Nav1.7-Targeted Inhibitor Cystine Knot Peptide.

Gonzales J, Demetrio de Souza Franca P, Jiang Y, Pirovano G, Kossatz S, Guru N, Yarilin D, Agwa AJ, Schroeder CI, Patel SG, Ganly I, King GF, Reiner T.

Bioconjug Chem. 2019 Nov 20;30(11):2879-2888. doi: 10.1021/acs.bioconjchem.9b00612. Epub 2019 Nov 8.

PMID:
31647222
2.

Intraoperative and postanesthesia care unit fluid administration as risk factors for postoperative complications in patients with head and neck cancer undergoing free tissue transfer.

Dooley BJ, Karassawa Zanoni D, Mcgill MR, Awad MI, Shah JP, Wong RJ, Broad C, Mehrara BJ, Ganly I, Patel SG.

Head Neck. 2019 Oct 8. doi: 10.1002/hed.25970. [Epub ahead of print]

PMID:
31593349
3.

Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.

Fan D, Ma J, Bell AC, Groen AH, Olsen KS, Lok BH, Leeman JE, Anderson E, Riaz N, McBride S, Ganly I, Shaha AR, Sherman EJ, Tsai CJ, Kang JJ, Lee NY.

Cancer. 2019 Oct 8. doi: 10.1002/cncr.32548. [Epub ahead of print]

PMID:
31593317
4.

Isthmusectomy in selected patients with well-differentiated thyroid carcinoma.

Park H, Harries V, McGill MR, Ganly I, Shah JP.

Head Neck. 2019 Oct 7. doi: 10.1002/hed.25968. [Epub ahead of print]

PMID:
31589005
5.

Long-Term Oncologic Outcomes After Curative Resection of Familial Medullary Thyroid Carcinoma.

Spanheimer PM, Ganly I, Chou J, Capanu M, Ghossein RA, Tuttle RM, Wong RJ, Shaha AR, Untch BR.

Ann Surg Oncol. 2019 Dec;26(13):4423-4429. doi: 10.1245/s10434-019-07869-9. Epub 2019 Sep 23.

PMID:
31549322
6.

Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?

Harries V, Wang LY, McGill M, Xu B, Tuttle RM, Wong RJ, Shaha AR, Shah JP, Ghossein R, Patel SG, Ganly I.

Surgery. 2019 Sep 9. pii: S0039-6060(19)30512-4. doi: 10.1016/j.surg.2019.03.031. [Epub ahead of print]

PMID:
31515125
7.

Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.

Ho AS, Ochoa A, Jayakumaran G, Zehir A, Valero Mayor C, Tepe J, Makarov V, Dalin MG, He J, Bailey M, Montesion M, Ross JS, Miller VA, Chan L, Ganly I, Dogan S, Katabi N, Tsipouras P, Ha P, Agrawal N, Solit DB, Futreal PA, El Naggar AK, Reis-Filho JS, Weigelt B, Ho AL, Schultz N, Chan TA, Morris LG.

J Clin Invest. 2019 Oct 1;129(10):4276-4289. doi: 10.1172/JCI128227.

8.
9.

Salvage surgery for recurrent larynx cancer.

Mimica X, Hanson M, Patel SG, McGill M, McBride S, Lee N, Dunn LA, Cracchiolo JR, Shah JP, Wong RJ, Ganly I, Cohen MA.

Head Neck. 2019 Nov;41(11):3906-3915. doi: 10.1002/hed.25925. Epub 2019 Aug 21.

PMID:
31433540
10.

Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens.

Mandapathil M, Lennon P, Ganly I, Patel SG, Shah JP.

Head Neck. 2019 Nov;41(11):3783-3787. doi: 10.1002/hed.25905. Epub 2019 Aug 7.

PMID:
31390117
11.

Polymorphous adenocarcinoma of salivary glands.

Mimica X, Katabi N, McGill MR, Hay A, Zanoni DK, Shah JP, Wong RJ, Cohen MA, Patel SG, Ganly I.

Oral Oncol. 2019 Aug;95:52-58. doi: 10.1016/j.oraloncology.2019.06.002. Epub 2019 Jun 7.

PMID:
31345394
12.

Surgical Management Patterns of Sinonasal Malignancy: A Population-Based Study.

Husain Q, Joshi RR, Cracchiolo JR, Roman BR, Ganly I, Tabar V, Cohen MA.

J Neurol Surg B Skull Base. 2019 Aug;80(4):371-379. doi: 10.1055/s-0038-1675233. Epub 2018 Oct 25.

PMID:
31316883
13.

Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach.

Xiao R, Joshi RR, Husain Q, Cracchiolo JR, Lee N, Tsai J, Yu Y, Chen L, Kang JJ, McBride S, Riaz N, Roman BR, Ganly I, Tabar V, Gray ST, Cohen MA.

Head Neck. 2019 Oct;41(10):3551-3563. doi: 10.1002/hed.25873. Epub 2019 Jul 11.

PMID:
31294897
14.

DNA methylation-based classification of sinonasal undifferentiated carcinoma.

Dogan S, Vasudevaraja V, Xu B, Serrano J, Ptashkin RN, Jung HJ, Chiang S, Jungbluth AA, Cohen MA, Ganly I, Berger MF, Momeni Boroujeni A, Ghossein RA, Ladanyi M, Chute DJ, Snuderl M.

Mod Pathol. 2019 Oct;32(10):1447-1459. doi: 10.1038/s41379-019-0285-x. Epub 2019 Jun 11.

PMID:
31186531
15.

Sex disparities in salivary malignancies: Does female sex impact oncological outcome?

Mimica X, McGill M, Hay A, Zanoni DK, Shah JP, Wong RJ, Ho AL, Cohen MA, Patel SG, Ganly I.

Oral Oncol. 2019 Jul;94:86-92. doi: 10.1016/j.oraloncology.2019.05.017. Epub 2019 May 22.

PMID:
31178218
16.

Minor salivary gland tumors of the head and neck-Memorial Sloan Kettering experience: Incidence and outcomes by site and histological type.

Hay AJ, Migliacci J, Karassawa Zanoni D, McGill M, Patel S, Ganly I.

Cancer. 2019 Oct 1;125(19):3354-3366. doi: 10.1002/cncr.32208. Epub 2019 Jun 7.

PMID:
31174233
17.

Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx.

Dogan S, Xu B, Middha S, Vanderbilt CM, Bowman AS, Migliacci J, Morris LGT, Seshan VE, Ganly I.

Int J Cancer. 2019 Dec 1;145(11):3152-3162. doi: 10.1002/ijc.32412. Epub 2019 May 30.

PMID:
31093971
18.

Immunogenic neoantigens derived from gene fusions stimulate T cell responses.

Yang W, Lee KW, Srivastava RM, Kuo F, Krishna C, Chowell D, Makarov V, Hoen D, Dalin MG, Wexler L, Ghossein R, Katabi N, Nadeem Z, Cohen MA, Tian SK, Robine N, Arora K, Geiger H, Agius P, Bouvier N, Huberman K, Vanness K, Havel JJ, Sims JS, Samstein RM, Mandal R, Tepe J, Ganly I, Ho AL, Riaz N, Wong RJ, Shukla N, Chan TA, Morris LGT.

Nat Med. 2019 May;25(5):767-775. doi: 10.1038/s41591-019-0434-2. Epub 2019 Apr 22.

19.

Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy-free survival in those refusing surgery.

Mimica X, Yu Y, McGill M, Barker CA, McBride S, Ganly I, Cracchiolo JR, Dunn LA, Katabi N, Sine K, Mah D, Lee A, Lee N, Cohen MA.

Head Neck. 2019 Aug;41(8):2741-2747. doi: 10.1002/hed.25751. Epub 2019 Apr 1.

PMID:
30933393
20.

Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer.

Andrade F, Rondeau G, Boucai L, Zeuren R, Shaha AR, Ganly I, Vaisman F, Corbo R, Tuttle M.

Arch Endocrinol Metab. 2019 Mar-Apr;63(2):137-141. doi: 10.20945/2359-3997000000112. Epub 2019 Mar 21.

21.

Immediate Dental Implantation in Oncologic Jaw Reconstruction: Workflow Optimization to Decrease Time to Full Dental Rehabilitation.

Allen RJ Jr, Shenaq DS, Rosen EB, Patel SG, Ganly I, Boyle JO, Nelson JA, Matros E.

Plast Reconstr Surg Glob Open. 2019 Jan 14;7(1):e2100. doi: 10.1097/GOX.0000000000002100. eCollection 2019 Jan.

22.

Short Review: Genomic Alterations in Hürthle Cell Carcinoma.

Ganly I, McFadden DG.

Thyroid. 2019 Apr;29(4):471-479. doi: 10.1089/thy.2019.0088.

PMID:
30848171
23.

Survival outcomes after treatment of cancer of the oral cavity (1985-2015).

Zanoni DK, Montero PH, Migliacci JC, Shah JP, Wong RJ, Ganly I, Patel SG.

Oral Oncol. 2019 Mar;90:115-121. doi: 10.1016/j.oraloncology.2019.02.001. Epub 2019 Feb 15.

PMID:
30846169
24.

Novel intraoperative radiotherapy utilizing prefabricated custom three-dimensionally printed high-dose-rate applicators.

Imber BS, Wolden SL, Stambuk HE, Matros E, Wexler LH, Drew AS, Rosen EB, Ganly I, Cohen GN, Damato AL.

Brachytherapy. 2019 May - Jun;18(3):277-284. doi: 10.1016/j.brachy.2019.01.012. Epub 2019 Feb 22.

PMID:
30803923
25.

Long-term functional and esthetic outcomes after fibula free flap reconstruction of the mandible.

Petrovic I, Baser R, Blackwell T, McCarthy C, Ganly I, Patel S, Cordeiro P, Shah J.

Head Neck. 2019 Jul;41(7):2123-2132. doi: 10.1002/hed.25666. Epub 2019 Feb 13.

PMID:
30761650
26.

Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects.

Ibrahimpasic T, Ghossein R, Shah JP, Ganly I.

Thyroid. 2019 Mar;29(3):311-321. doi: 10.1089/thy.2018.0509.

PMID:
30747050
27.

Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.

Xu B, Reznik E, Tuttle RM, Knauf J, Fagin JA, Katabi N, Dogan S, Aleynick N, Seshan V, Middha S, Enepekides D, Casadei GP, Solaroli E, Tallini G, Ghossein R, Ganly I.

Endocrine. 2019 Apr;64(1):97-108. doi: 10.1007/s12020-019-01848-6. Epub 2019 Jan 28.

PMID:
30689169
28.

A Virtual Surgical Planning Algorithm for Delayed Maxillomandibular Reconstruction.

Stranix JT, Stern CS, Rensberger M, Ganly I, Boyle JO, Allen RJ Jr, Disa JJ, Mehrara BJ, Garfein ES, Matros E.

Plast Reconstr Surg. 2019 Apr;143(4):1197-1206. doi: 10.1097/PRS.0000000000005452.

PMID:
30676509
29.

Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus.

Ganly I, Yang L, Giese RA, Hao Y, Nossa CW, Morris LGT, Rosenthal M, Migliacci J, Kelly D, Tseng W, Hu J, Li H, Brown S, Pei Z.

Int J Cancer. 2019 Aug 1;145(3):775-784. doi: 10.1002/ijc.32152. Epub 2019 Feb 19.

PMID:
30671943
30.

Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma.

Joshi RR, Husain Q, Roman BR, Cracchiolo J, Yu Y, Tsai J, Kang J, McBride S, Lee NY, Morris L, Ganly I, Tabar V, Cohen MA.

J Surg Oncol. 2019 Jan;119(1):130-142. doi: 10.1002/jso.25293. Epub 2018 Nov 22.

PMID:
30466166
31.

Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer.

Shaha AR, Migliacci JC, Nixon IJ, Wang LY, Wong RJ, Morris LGT, Patel SG, Shah JP, Tuttle RM, Ganly I.

Surgery. 2019 Jan;165(1):6-11. doi: 10.1016/j.surg.2018.04.078. Epub 2018 Nov 8.

PMID:
30415873
32.

Remote-access thyroid surgery-progress, assessment, and reflection.

Patel KN, Ganly I, Shaha AR.

J Surg Oncol. 2018 Sep;118(3):388-389. doi: 10.1002/jso.25167. Epub 2018 Sep 3. No abstract available.

PMID:
30176175
33.

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.

Ganly I, Makarov V, Deraje S, Dong Y, Reznik E, Seshan V, Nanjangud G, Eng S, Bose P, Kuo F, Morris LGT, Landa I, Carrillo Albornoz PB, Riaz N, Nikiforov YE, Patel K, Umbricht C, Zeiger M, Kebebew E, Sherman E, Ghossein R, Fagin JA, Chan TA.

Cancer Cell. 2018 Aug 13;34(2):256-270.e5. doi: 10.1016/j.ccell.2018.07.002.

34.

Validation and assessment of discordance of the 8th edition AJCC (American Joint Committee on Cancer) clinical and pathologic staging systems in patients with p16+ oropharyngeal cancer treated with surgery and adjuvant radiation at a single institution.

Gupta P, Migliacci JC, Hay A, Rosenthal M, Mimica X, Lee N, Wong RJ, Shah J, Patel S, Ganly I.

Oral Oncol. 2018 Aug;83:140-146. doi: 10.1016/j.oraloncology.2018.06.024. Epub 2018 Jun 23. No abstract available.

35.

Ameloblastomas of the mandible and maxilla.

Petrovic ID, Migliacci J, Ganly I, Patel S, Xu B, Ghossein R, Huryn J, Shah J.

Ear Nose Throat J. 2018 Jul;97(7):E26-E32.

36.
37.

Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.

Katsoulakis E, Leeman JE, Lok BH, Shi W, Zhang Z, Tsai JC, McBride SM, Sherman EJ, Cohen M, Wong R, Ganly I, Lee NY, Riaz N.

Laryngoscope. 2018 Nov;128(11):2539-2545. doi: 10.1002/lary.27191. Epub 2018 Apr 10.

38.

Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution.

Mizrachi A, Migliacci JC, Montero PH, McBride S, Shah JP, Patel SG, Ganly I.

Oral Oncol. 2018 Mar;78:94-101. doi: 10.1016/j.oraloncology.2018.01.020. Epub 2018 Feb 20.

39.

Do we need a different staging system for tongue and gingivobuccal complex squamous cell cancers?

Gupta P, Migliacci JC, Montero PH, Zanoni DK, Shah JP, Patel SG, Ganly I.

Oral Oncol. 2018 Mar;78:64-71. doi: 10.1016/j.oraloncology.2018.01.013. Epub 2018 Feb 20.

40.

Validation of nomograms for overall survival, cancer-specific survival, and recurrence in carcinoma of the major salivary glands.

Hay A, Migliacci J, Zanoni DK, Patel S, Yu C, Kattan MW, Ganly I.

Head Neck. 2018 May;40(5):1008-1015. doi: 10.1002/hed.25079. Epub 2018 Feb 1.

41.

Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer.

Hayes RB, Ahn J, Fan X, Peters BA, Ma Y, Yang L, Agalliu I, Burk RD, Ganly I, Purdue MP, Freedman ND, Gapstur SM, Pei Z.

JAMA Oncol. 2018 Mar 1;4(3):358-365. doi: 10.1001/jamaoncol.2017.4777.

42.

Detection of HPV related oropharyngeal cancer in oral rinse specimens.

Rosenthal M, Huang B, Katabi N, Migliacci J, Bryant R, Kaplan S, Blackwell T, Patel S, Yang L, Pei Z, Tang YW, Ganly I.

Oncotarget. 2017 Nov 25;8(65):109393-109401. doi: 10.18632/oncotarget.22682. eCollection 2017 Dec 12.

43.

Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage-Case Report.

Krebs S, Ganly I, Ghossein R, Yang J, Yahalom J, Schöder H.

Front Oncol. 2017 Nov 27;7:284. doi: 10.3389/fonc.2017.00284. eCollection 2017.

44.

Haemorrhage following transoral robotic surgery.

Hay A, Migliacci J, Karassawa Zanoni D, Boyle JO, Singh B, Wong RJ, Patel SG, Ganly I.

Clin Otolaryngol. 2018 Apr;43(2):638-644. doi: 10.1111/coa.13041. Epub 2017 Dec 26.

45.

Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma.

Cracchiolo JR, Patel K, Migliacci JC, Morris LT, Ganly I, Roman BR, McBride SM, Tabar VS, Cohen MA.

J Surg Oncol. 2018 Mar;117(4):756-764. doi: 10.1002/jso.24923. Epub 2017 Nov 28.

46.

Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.

Dalin MG, Katabi N, Persson M, Lee KW, Makarov V, Desrichard A, Walsh LA, West L, Nadeem Z, Ramaswami D, Havel JJ, Kuo F, Chadalavada K, Nanjangud GJ, Ganly I, Riaz N, Ho AL, Antonescu CR, Ghossein R, Stenman G, Chan TA, Morris LGT.

Nat Commun. 2017 Oct 30;8(1):1197. doi: 10.1038/s41467-017-01178-z.

47.

Association of Surgical Approach and Margin Status With Oncologic Outcomes Following Gross Total Resection for Sinonasal Melanoma.

Sayed Z, Migliacci JC, Cracchiolo JR, Barker CA, Lee NY, McBride SM, Tabar VS, Ganly I, Patel SG, Morris LT, Roman BR, Shoushtari AN, Cohen MA.

JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1220-1227. doi: 10.1001/jamaoto.2017.2011. No abstract available.

48.

Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.

Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, Patel S, Untch B, Ganly I, Shaha AR, Shah JP, Pace M, Li D, Bach A, Lin O, Whiting A, Ghossein R, Landa I, Sabra M, Boucai L, Fish S, Morris LGT.

JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1015-1020. doi: 10.1001/jamaoto.2017.1442.

49.

Post-treatment surveillance of thyroid cancer.

Wang LY, Ganly I.

Eur J Surg Oncol. 2018 Mar;44(3):357-366. doi: 10.1016/j.ejso.2017.07.004. Epub 2017 Jul 19. Review.

PMID:
28754228
50.

Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.

Xu B, Drill E, Ho A, Ho A, Dunn L, Prieto-Granada CN, Chan T, Ganly I, Ghossein R, Katabi N.

Am J Surg Pathol. 2017 Oct;41(10):1422-1432. doi: 10.1097/PAS.0000000000000918.

Supplemental Content

Support Center